Exosomal tumor-suppressive microRNAs as novel cancer therapy. "Exocure" is another choice for cancer treatment

Advanced Drug Delivery Reviews

Volumn 65, Issue 3, 2013, Pages 376-382

  Kosaka, Nobuyoshi ^a   Takeshita, Fumitaka ^a   Yoshioka, Yusuke ^a,b,d   Hagiwara, Keitaro ^a,c   Katsuda, Takeshi ^a   Ono, Makiko ^a   Ochiya, Takahiro ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b WASEDA UNIVERSITY   (Japan)

^c TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^d JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

Author keywords

Cell cell communication; Drug delivery system; Exosome; Exosomes; Microvesicle; Secretory microRNAs; Small RNA therapy; Tumor initiation; Tumor suppressive microRNA

Indexed keywords

CELL-CELL COMMUNICATIONS; DRUG DELIVERY SYSTEM; EXOSOME; EXOSOMES; MICRORNAS; MICROVESICLE; SMALL RNA;

DISEASES; DRUG DELIVERY; GENE EXPRESSION; PHYSIOLOGY; TUMORS;

RNA;

ANTINEOPLASTIC AGENT; MICRORNA; MICRORNA 143; MICRORNA 15A; MICRORNA 16; MICRORNA 22; RNA;

BREAST CANCER; CANCER GROWTH; CANCER INHIBITION; CANCER THERAPY; CHRONIC LYMPHATIC LEUKEMIA; COLORECTAL CANCER; DRUG MECHANISM; EXOSOME; LUNG CANCER; OSTEOSARCOMA; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; UTERINE CERVIX CANCER;

ANIMALS; DISEASE PROGRESSION; EXOSOMES; GENE REGULATORY NETWORKS; HUMANS; MICRORNAS; NEOPLASMS; RNA, SMALL INTERFERING;

EID: 84874967621     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2012.07.011     Document Type: Review

References (62)

1. Kim V.N., Han J., Siomi M.C. Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 2009 Feb, 10(2):126-139.
2. miRBase Release 18 http://www.mirbase.org/.
3. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009 Jan 23, 136(2):215-233.
4. Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 2009 Oct, 10(10):704-714.
5. Suzuki H.I., Miyazono K. Emerging complexity of microRNA generation cascades. J. Biochem. 2011 Jan, 149(1):15-25.
6. Kosaka N., Ochiya T. Unraveling the mystery of cancer by secretory microRNA: horizontal microRNA transfer between living cells. Front Genet. 2011, 2:97.
7. Takamizawa J., Konishi H., Yanagisawa K., Tomida S., Osada H., Endoh H., et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004 Jun 1, 64(11):3753-3756.
8. Johnson S.M., Grosshans H., Shingara J., Byrom M., Jarvis R., Cheng A., et al. RAS is regulated by the let-7 microRNA family. Cell 2005 Mar 11, 120(5):635-647.
9. Lee Y.S., Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 2007 May 1, 21(9):1025-1030.
10. Mayr C., Hemann M.T., Bartel D.P. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 2007 Mar 16, 315(5818):1576-1579.
11. Yu F., Yao H., Zhu P., Zhang X., Pan Q., Gong C., et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 2007 Dec 14, 131(6):1109-1123.
12. Zhou B.B., Zhang H., Damelin M., Geles K.G., Grindley J.C., Dirks P.B. Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat. Rev. Drug Discov. 2009 Oct, 8(10):806-823.
13. Tokumaru S., Suzuki M., Yamada H., Nagino M., Takahashi T. let-7 regulates Dicer expression and constitutes a negative feedback loop. Carcinogenesis 2008 Nov, 29(11):2073-2077.
14. Viswanathan S.R., Daley G.Q. Lin28: a microRNA regulator with a macro role. Cell 2010 Feb 19, 140(4):445-449.
15. Chang T.C., Zeitels L.R., Hwang H.W., Chivukula R.R., Wentzel E.A., Dews M., Jung J., Gao P., Dang C.V., Beer M.A., Thomas-Tikhonenko A., Mendell J.T. Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc. Natl. Acad. Sci. U. S. A. 2009 Mar 3, 106(9):3384-3389.
16. Iliopoulos D., Hirsch H.A., Struhl K. An epigenetic switch involving NF-kappaB, Lin28, Let-7 microRNA, and IL6 links inflammation to cell transformation. Cell 2009 Nov 13, 139(4):693-706.
17. Heo I., Joo C., Kim Y.K., Ha M., Yoon M.J., Cho J., Yeom K.H., Han J., Kim V.N. TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation. Cell 2009 Aug 21, 138(4):696-708.
18. Lehrbach N.J., Armisen J., Lightfoot H.L., Murfitt K.J., Bugaut A., Balasubramanian S., Miska E.A. LIN-28 and the poly(U) polymerase PUP-2 regulate let-7 microRNA processing in Caenorhabditis elegans. Nat. Struct. Mol. Biol. 2009 Oct, 16(10):1016-1020.
19. Hagan J.P., Piskounova E., Gregory R.I. Lin28 recruits the TUTase Zcchc11 to inhibit let-7 maturation in mouse embryonic stem cells. Nat. Struct. Mol. Biol. 2009 Oct, 16(10):1021-1025.
20. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U. S. A. 2002 Nov 26, 99(24):15524-15529.
21. Calin G.A., Ferracin M., Cimmino A., Di Leva G., Shimizu M., Wojcik S.E., et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med. 2005 Oct 27, 353(17):1793-1801.
22. Cimmino A., Calin G.A., Fabbri M., Iorio M.V., Ferracin M., Shimizu M., et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. U. S. A. 2005 Sep 27, 102(39):13944-13949.
23. Bonci D., Coppola V., Musumeci M., Addario A., Giuffrida R., Memeo L., et al. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat. Med. 2008 Nov, 14(11):1271-1277.
24. Takeshita F., Patrawala L., Osaki M., Takahashi R.U., Yamamoto Y., Kosaka N., et al. Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol. Ther. 2010 Jan, 18(1):181-187.
25. Marchini S., Cavalieri D., Fruscio R., Calura E., Garavaglia D., Nerini I.F., Mangioni C., Cattoretti G., Clivio L., Beltrame L., Katsaros D., Scarampi L., Menato G., Perego P., Chiorino G., Buda A., Romualdi C., D'Incalci M. Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections. Lancet Oncol. 2011 Mar, 12(3):273-285.
26. Chen X., Guo X., Zhang H., Xiang Y., Chen J., Yin Y., Cai X., Wang K., Wang G., Ba Y., Zhu L., Wang J., Yang R., Zhang Y., Ren Z., Zen K., Zhang J., Zhang C.Y. Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 2009 Mar 12, 28(10):1385-1392.
27. Clapé C., Fritz V., Henriquet C., Apparailly F., Fernandez P.L., Iborra F., Avancès C., Villalba M., Culine S., Fajas L. miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice. PLoS One 2009 Oct 26, 4(10):e7542.
28. Liu L., Yu X., Guo X., Tian Z., Su M., Long Y., Huang C., Zhou F., Liu M., Wu X., Wang X. miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2. Mol. Med. Rep. 2012 Mar, 5(3):753-760.
29. Wang X., Tang S., Le S.Y., Lu R., Rader J.S., Meyers C., Zheng Z.M. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 2008 Jul 2, 3(7):e2557.
30. Lui W.O., Pourmand N., Patterson B.K., Fire A. Patterns of known and novel small RNAs in human cervical cancer. Cancer Res. 2007 Jul 1, 67(13):6031-6043.
31. Osaki M., Takeshita F., Sugimoto Y., Kosaka N., Yamamoto Y., Yoshioka Y., et al. MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression. Mol. Ther. 2011 Jun, 19(6):1123-1130.
32. Xu D., Takeshita F., Hino Y., Fukunaga S., Kudo Y., Tamaki A., et al. miR-22 represses cancer progression by inducing cellular senescence. J. Cell Biol. 2011 Apr 18, 93(2):409-424.
33. Kim D.H., Rossi J.J. Strategies for silencing human disease using RNA interference. Nat. Rev. Genet. 2007 Mar, 8(3):173-184.
34. Tiemann K., Rossi J.J. RNAi-based therapeutics-current status, challenges and prospects. EMBO Mol. Med. 2009 Jun, 1(3):142-151.
35. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007 Jun, 9(6):654-659.
36. Simons M., Raposo G. Exosomes-vesicular carriers for intercellular communication. Curr. Opin. Cell Biol. 2009 Aug, 21(4):575-581.
37. Théry C., Ostrowski M., Segura E. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 2009 Aug, 9(8):581-593.
38. Chaput N., Théry C. Exosomes: immune properties and potential clinical implementations. Semin. Immunopathol. 2011 Sep, 33(5):419-440.
39. Théry C. Exosomes: secreted vesicles and intercellular communications. Biol Rep. 2011, 3:15. (F1000).
40. Pegtel D.M., Cosmopoulos K., Thorley-Lawson D.A., van Eijndhoven M.A., Hopmans E.S., Lindenberg J.L., et al. Functional delivery of viral miRNAs via exosomes. Proc. Natl. Acad. Sci. U. S. A. 2010 Apr 6, 107(14):6328-6333.
41. Zhang Y., Liu D., Chen X., Li J., Li L., Bian Z., et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell 2010 Jul 9, 39(1):133-144.
42. Kosaka N., Iguchi H., Yoshioka Y., Takeshita F., Matsuki Y., Ochiya T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 2010 Jun 4, 285(23):17442-17452.
43. Mittelbrunn M., Gutiérrez-Vázquez C., Villarroya-Beltri C., González S., Sánchez-Cabo F., González M.Á., Bernad A., Sánchez-Madrid F. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat. Commun. 2011, 2:282.
44. Montecalvo A., Larregina A.T., Shufesky W.J., Beer Stolz D., Sullivan M.L., Karlsson J.M., Baty C.J., Gibson G.A., Erdos G., Wang Z., Milosevic J., Tkacheva O.A., Divito S.J., Jordan R., Lyons-Weiler J., Watkins S.C., Morelli A.E. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 2012 Jan 19, 119(3):756-766.
45. Yang M., Chen J., Su F., Yu B., Su F., Lin L., Liu Y., Huang J.D., Song E. Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol. Cancer 2011 Sep 22, 10:117.
46. Kogure T., Lin W.L., Yan I.K., Braconi C., Patel T. Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology 2011 Oct, 54(4):1237-1248.
47. Kosaka N., Iguchi H., Yoshioka Y., Hagiwara K., Takeshita F., Ochiya T. Competitive interactions of cancer cells and normal cells via secretory microRNAs. J. Biol. Chem. 2012 Jan 6, 287(2):1397-1405.
48. Alvarez-Erviti L., Seow Y., Yin H., Betts C., Lakhal S., Wood M.J. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 2011 Apr, 29(4):341-345.
49. Pan Q., Ramakrishnaiah V., Henry S., Fouraschen S., de Ruiter P.E., Kwekkeboom J., Tilanus H.W., Janssen H.L., van der Laan L.J. Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi). Gut 2011 Dec 23, (Epub ahead of print).
50. Trajkovic K., Hsu C., Chiantia S., Rajendran L., Wenzel D., Wieland F., Schwille P., Brügger B., Simons M. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 2008 Feb 29, 319(5867):1244-1247.
51. Ostrowski M., Carmo N.B., Krumeich S., Fanget I., Raposo G., Savina A., Moita C.F., Schauer K., Hume A.N., Freitas R.P., Goud B., Benaroch P., Hacohen N., Fukuda M., Desnos C., Seabra M.C., Darchen F., Amigorena S., Moita L.F., Thery C. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat. Cell Biol. 2010 Jan, 12(1):19-30. (sup pp 1-13).
52. Hsu C., Morohashi Y., Yoshimura S., Manrique-Hoyos N., Jung S., Lauterbach M.A., Bakhti M., Grønborg M., Möbius W., Rhee J., Barr F.A., Simons M. Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. J. Cell Biol. 2010 Apr 19, 189(2):223-232.
53. Amzallag N., Passer B.J., Allanic D., Segura E., Théry C., Goud B., Amson R., Telerman A. TSAP6 facilitates the secretion of translationally controlled tumor protein/histamine-releasing factor via a nonclassical pathway. J. Biol. Chem. 2004 Oct 29, 279(44):46104-46112.
54. Yu X., Harris S.L., Levine A.J. The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res. 2006 May 1, 66(9):4795-4801.
55. Lespagnol A., Duflaut D., Beekman C., Blanc L., Fiucci G., Marine J.C., Vidal M., Amson R., Telerman A. Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice. Cell Death Differ. 2008 Nov, 15(11):1723-1733.
56. Lehmann B.D., Paine M.S., Brooks A.M., McCubrey J.A., Renegar R.H., Wang R., Terrian D.M. Senescence-associated exosome release from human prostate cancer cells. Cancer Res. 2008 Oct 1, 68(19):7864-7871.
57. Yu X., Riley T., Levine A.J. The regulation of the endosomal compartment by p53 the tumor suppressor gene. FEBS J. 2009 Apr, 276(8):2201-2212.
58. Savina A., Furlán M., Vidal M., Colombo M.I. Exosome release is regulated by a calcium-dependent mechanism in K562 cells. J. Biol. Chem. 2003 May 30, 278(22):20083-20090.
59. Savina A., Fader C.M., Damiani M.T., Colombo M.I. Rab11 promotes docking and fusion of multivesicular bodies in a calcium-dependent manner. Traffic 2005 Feb, 6(2):131-143.
60. Kuwabara Y., Ono K., Horie T., Nishi H., Nagao K., Kinoshita M., Watanabe S., Baba O., Kojima Y., Shizuta S., Imai M., Tamura T., Kita T., Kimura T. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ. Cardiovasc. Genet. 2011 Aug 1, 4(4):446-454.
61. Zhang L., Hou D., Chen X., Li D., Zhu L., Zhang Y., Li J., Bian Z., Liang X., Cai X., Yin Y., Wang C., Zhang T., Zhu D., Zhang D., Xu J., Chen Q., Ba Y., Liu J., Wang Q., Chen J., Wang J., Wang M., Zhang Q., Zhang J., Zen K., Zhang C.Y. Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res. 2012 Jan, 22(1):107-126.
62. Clayton A., Harris C.L., Court J., Mason M.D., Morgan B.P. Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59. Eur. J. Immunol. 2003 Feb, 33(2):522-531.